IHS Chemical Week

People & Business :: M&A

Pfizer confirms interest in AstraZeneca, will hold investor call today

3:22 AM MDT | April 28, 2014 | Natasha Alperowicz

Pfizer said today that it approached AstraZeneca on Saturday seeking to renew discussions, which could lead to the merger of the two companies. The news follows an initial approach by Pfizer in January, which was rejected by AstraZeneca. Pfizer says that such a transaction would bring together highly complementary, innovative, and established pharmaceutical businesses, enhancing the combined company’s ability to meet patients’ needs.   Pfizer says that, in January, it submitted a preliminary, nonbinding indication of interest to the board of...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week subscriber yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine a year in print or digital format
  • Real time news and analysis on chemweek.com 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now


contact us | about us | privacy policy | sitemap

ihsCopyright © IHS, Inc.All rights reserved.Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa